ACCESSION: MSBNK-SMB_Measured-HSA015P0114014
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 42
COMMENT: RAW_SPEC {'EL03_pos_1269': {'bp': 3744703.0, 'sum': 7700172.0}, 'EL13_pos_1216': {'bp': 1601220.0, 'sum': 3963142.0}, 'EL04_pos_1279': {'bp': 1665475.0, 'sum': 3798225.0}, 'EL09_pos_1273': {'bp': 1842575.0, 'sum': 4073912.0}, 'EL06_pos_1273': {'bp': 1909610.0, 'sum': 4425893.0}, 'EL20_pos_1267': {'bp': 1805108.0, 'sum': 4029934.0}, 'EL15_pos_1222': {'bp': 1823102.0, 'sum': 4356864.0}, 'EL05_pos_1215': {'bp': 1893608.0, 'sum': 4907488.0}, 'EL21_pos_1267': {'bp': 1929176.0, 'sum': 4143663.0}, 'EL10_pos_1215': {'bp': 1620223.0, 'sum': 3771318.0}, 'EL11_pos_1216': {'bp': 1765332.0, 'sum': 4091208.0}, 'EL07_pos_1216': {'bp': 1724428.0, 'sum': 4108528.0}, 'EL06_pos_1215': {'bp': 1833694.0, 'sum': 4697710.0}, 'EL21_pos_1211': {'bp': 1866954.0, 'sum': 4781398.0}, 'EL05_pos_1273': {'bp': 1973480.0, 'sum': 4436575.0}, 'EL17_pos_1211': {'bp': 1719104.0, 'sum': 4260237.0}, 'EL19_pos_1221': {'bp': 1865031.0, 'sum': 5026882.0}, 'EL19_pos_1279': {'bp': 2002797.0, 'sum': 4541193.0}, 'EL20_pos_1211': {'bp': 1715206.0, 'sum': 4648538.0}, 'EL22_pos_1222': {'bp': 1838856.0, 'sum': 4374921.0}, 'EL02_pos_1219': {'bp': 1926221.0, 'sum': 4963747.0}, 'EL22_pos_1280': {'bp': 2109459.0, 'sum': 4664657.0}, 'EL12_pos_1215': {'bp': 2005055.0, 'sum': 4430058.0}, 'EL14_pos_1223': {'bp': 1717856.0, 'sum': 4050065.0}, 'EL04_pos_1223': {'bp': 1670043.0, 'sum': 4028894.0}, 'EL24_pos_1222': {'bp': 1526719.0, 'sum': 3888099.0}, 'EL16_pos_1217': {'bp': 1718762.0, 'sum': 4229551.0}, 'EL18_pos_1273': {'bp': 1757955.0, 'sum': 4135547.0}, 'EL10_pos_1274': {'bp': 1810273.0, 'sum': 3904666.0}, 'EL23_pos_1273': {'bp': 1742326.0, 'sum': 4072484.0}, 'EL14_pos_1279': {'bp': 1700465.0, 'sum': 3970034.0}, 'EL11_pos_1273': {'bp': 1688367.0, 'sum': 3748382.0}, 'EL07_pos_1274': {'bp': 1861123.0, 'sum': 4104384.0}, 'EL16_pos_1273': {'bp': 1835698.0, 'sum': 4216909.0}, 'EL18_pos_1215': {'bp': 1647833.0, 'sum': 4259549.0}, 'EL12_pos_1274': {'bp': 1934607.0, 'sum': 4157880.0}, 'EL23_pos_1216': {'bp': 1720191.0, 'sum': 4139411.0}, 'EL24_pos_1279': {'bp': 1696964.0, 'sum': 3953122.0}, 'EL01_pos_1220': {'bp': 1411201.0, 'sum': 3827976.0}, 'EL08_pos_1274': {'bp': 1746926.0, 'sum': 4002824.0}, 'EL09_pos_1215': {'bp': 1704083.0, 'sum': 4283796.0}, 'EL08_pos_1215': {'bp': 1522675.0, 'sum': 4012225.0}}
COMMENT: RETENTION_TIME_STDEV 0.046
COMMENT: PRECURSOR_M/Z_RAW 114.066643
COMMENT: PRECURSOR_M/Z_STDEV 0.000044
COMMENT: PRECURSOR_IN_MS1 mz 114.066226; int 52.032; delta(ppm) 0.650188
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+ACN+Na; mz 145.049526; int 12.664; cor 0.673
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.363; C4H7N3O; [M+H]+; delta(ppm) 0.362643
COMMENT: PROPOSED_MF SevenGoldenRules 0.531; C3H3N3; [M+CH3OH+H]+; delta(ppm) 0.530650
COMMENT: PROPOSED_MF MS-FINDER 3.077; C4H7N3O; [M+H]+; delta(ppm) 0.356816
COMMENT: PROPOSED_MF MS-FINDER 2.227; C3H3N3; [M+CH3OH+H]+; delta(ppm) 0.356816
COMMENT: PROPOSED_MF SIRIUS5_Sirius 25.421; C4H7N3O; [M+H]+; delta(ppm) 0.356816
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H7N3O; [M+H]+; delta(ppm) 0.356816
COMMENT: PROPOSED_MF SIRIUS6_Sirius 41.785; C4H7N3O; [M+H]+; delta(ppm) 0.356816
COMMENT: PROPOSED_MF SIRIUS6_Sirius 41.785; C3H3N3; [M+CH4O+H]+; delta(ppm) 0.356816
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.980; C6H9O2; [M+H]+; delta(ppm) -11.413967
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.980; C5H5O; [M+CH4O+H]+; delta(ppm) -11.413967
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.472; C2H5N6; [M+H]+; delta(ppm) 12.127875
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.456; FH4N3O; [M+CH4O+H]+; delta(ppm) -9.660551
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H7N3O; [M+H]+; delta(ppm) 0.356816
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C3H3N3; [M+CH4O+H]+; delta(ppm) 0.356816
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.516; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; CN1C=C(O)N=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.467; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; CN1CC(=O)NC1=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.333; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; CN(CCC#N)N=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; C1C=CNN1C(=O)N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.524; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; Creatinine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.772; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.706; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.691; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.633; JIHQDMXYYFUGFV-UHFFFAOYSA-N; [M+CH3OH+H]+; 1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.581; FYADHXFMURLYQI-UHFFFAOYSA-N; [M+CH3OH+H]+; 1,2,4-triazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.529; JYEUMXHLPRZUAT-UHFFFAOYSA-N; [M+CH3OH+H]+; 1,2,3-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JYEUMXHLPRZUAT-UHFFFAOYSA-N; [M+CH3OH+H]+; 1,2,3-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.964; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.950; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.900; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; Creatinine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.650; FYADHXFMURLYQI-UHFFFAOYSA-N; [M+CH3OH+H]+; 1,2,4-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.214; JIHQDMXYYFUGFV-UHFFFAOYSA-N; [M+CH3OH+H]+; 1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; JYEUMXHLPRZUAT-UHFFFAOYSA-N; [M+CH3OH+H]+; triazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.596; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methyl-4H-imidazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.640; JIHQDMXYYFUGFV-UHFFFAOYSA-N; [M+CH3OH+H]+; 1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.210; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; N-(2-cyanoethyl)-N-methylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.147; HJEVQOSZWIDFQJ-UHFFFAOYSA-N; [M+H]+; 2-(2H-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; DLLDJWMWMVUIDZ-UHFFFAOYSA-N; [M+H]+; (3-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; XKKMMJLWDOKNEW-UHFFFAOYSA-N; [M+H]+; (1-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; PKHVUMMJMYKRNO-UHFFFAOYSA-N; [M+H]+; 2-(triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.027; OMFADAFZDYXVOK-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; MKSFCAQPDWJPND-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.010; CIFUFRVSHZKBEO-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.003; KNIARYZRPMJYFH-UHFFFAOYSA-N; [M+H]+; 2-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.996; PFBCKBGKRFYNLE-UHFFFAOYSA-N; [M+H]+; (5-methyl-2H-triazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.995; YOSYLAYVXLOORB-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; OTERRMWTPZGJLB-UHFFFAOYSA-N; [M+H]+; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.909; WYZRLXYOIMXEBO-UHFFFAOYSA-N; [M+H]+; 1-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; BVNFZLFQKJYVDJ-UHFFFAOYSA-N; [M+H]+; 3,4-dimethyl-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; VUYWQWFWWHLKFG-UHFFFAOYSA-N; [M+H]+; 4-amino-5-methyl-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; LFSXUCZAZSQBPW-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.867; HGPUJQWMCPURNO-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; BMTFHVKZYIOHBE-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; XGKOIOPVLYCTRF-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-4H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.803; YKTPXKSUWIQBML-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2,5-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.795; HUSLEZCKWCUICB-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; NZORXPUYHVZTQG-UHFFFAOYSA-N; [M+H]+; (3-amino-1H-pyrazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; YGVFIVSNVVUSCS-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; FOOFYKFJNMAAQE-UHFFFAOYSA-N; [M+H]+; N-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.767; HKIXGXYGOILGSX-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.767; CIHQZPVUYBHNQO-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.740; KPBSGOLXLCARIL-UHFFFAOYSA-N; [M+H]+; (5-methyl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.712; HNXYWYOVPHLAQF-UHFFFAOYSA-N; [M+H]+; N,4-dimethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; IRPLFUJJHBGEAL-UHFFFAOYSA-N; [M+H]+; 3-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.671; QUAQZVSGXQVIEP-UHFFFAOYSA-N; [M+H]+; (2-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.666; RTCYUGLJCAPLPD-UHFFFAOYSA-N; [M+H]+; (2-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.663; AUZHYHBJZVEQNI-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.659; CLVALLQETQTQMV-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.655; XHSTYRIUVMKGDX-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.649; WEDYTSQNYJKOPC-UHFFFAOYSA-N; [M+H]+; (1-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.632; NPBUMVMXXGQOEG-UHFFFAOYSA-N; [M+H]+; (3-methyl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.552; XJUQLFVCCWNFJJ-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.539; DSFUCCQCXNNWLA-UHFFFAOYSA-N; [M+H]+; 3-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.526; YWXPPKJKSSLZOD-UHFFFAOYSA-N; [M+H]+; 5-(methoxymethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.521; LODVFGWSULLZAU-UHFFFAOYSA-N; [M+H]+; 4-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.413; KXLLKSHFFVQKTQ-UHFFFAOYSA-N; [M+H]+; 2-cyanoethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.400; GZDJNVITGJORKZ-UHFFFAOYSA-N; [M+H]+; ethyl N'-cyanocarbamimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.320; YUTNQQHHUYYBFA-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.232; MTHUPGKUEISSDE-UHFFFAOYSA-N; [M+H]+; 2-amino-N-(cyanomethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.723; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.320; KXLLKSHFFVQKTQ; [M+H]+; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -171.922; OMFADAFZDYXVOK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.724; HZDLDFBKYBGNHG; [M+H]+; 3-Methylnitrosaminopropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.526; CMIPWACBRYWGPN; [M+H]+; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.712; HGPUJQWMCPURNO; [M+H]+; Ambcb4035725
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -217.483; OTERRMWTPZGJLB; [M+H]+; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -224.851; XHSTYRIUVMKGDX; [M+H]+; 2-NH2-5-ET-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.765; MKSFCAQPDWJPND; [M+H]+; Azamuscimol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -248.217; IRPLFUJJHBGEAL; [M+H]+; 5-amino-1-methyl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.403; RTCYUGLJCAPLPD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.147; CLVALLQETQTQMV; [M+H]+; triazolylethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -297.615; DLLDJWMWMVUIDZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -353.594; PKHVUMMJMYKRNO; [M+H]+; 2-(1-triazolyl)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.400; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H8N3O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 1.997
MS$FOCUSED_ION: PRECURSOR_M/Z 114.066229
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-6900000000-c504c26398ab07a1f172
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0388121 5.2605 53.039510 1.3952 1.38 0.0323 35 f{C4H5}/4.44ppm,p-H3N3O1
  55.0181174 35.7023 55.018825 0.9270 23.05 0.6615 42 f{C3H3O1}/5.02ppm,p-C1H5N3
  55.0545022 26.7663 55.055210 0.6539 4.39 0.3945 42 f{C4H7}/5.01ppm,p-H1N3O1
  56.0497378 30.0565 56.050450 0.9813 23.80 0.6302 41 f{C3H6N1}/4.68ppm,p-C1H2N2O1
  57.0336937 8.7134 57.034410 0.9643 3.72 -0.6450 35 f{C3H5O1}/3.55ppm,p-C1H3N3
  67.0544085 26.3239 67.055150 0.7457 2.76 -0.0487 42 ?
  68.0496476 25.8114 68.050390 0.7788 3.46 -0.3706 42 f{C4H6N1}/2.53ppm,p-H2N2O1
  69.0336170 28.6589 69.034360 0.7098 3.42 -0.1226 33 f{C4H5O1}/1.82ppm,p-H3N3
  69.0700170 129.3803 69.070760 0.3764 7.23 -0.1006 42 ?
  70.0652467 127.2251 70.065990 0.6137 116.09 0.5892 42 f{C4H8N1}/1.73ppm,p-N2O1
  71.0492368 12.6377 71.049980 0.9712 2.56 0.4157 42 f{C4H7O1}/1.34ppm,p-H1N3
  71.0856268 10.7204 71.086370 0.8018 2.39 0.0347 42 ?
  72.0445088 5.2451 72.045252 1.3742 1.84 0.5424 30 f{C3H6N1O1}/1.65ppm,p-C1H2N2
  72.0808721 15.3729 72.081615 0.9018 2.70 0.0468 40 ?
  72.9372376 41.7532 72.937980 0.5621 5.97 -0.2786 41 ?
  73.0468777 9.1383 73.047620 1.0952 2.23 0.1115 39 ?
  78.9498125 12.3184 78.950545 0.9500 3.81 -0.6304 42 ?
  79.0542978 169.3159 79.055030 0.3289 8.29 -0.2032 42 ?
  79.9489402 6.3984 79.949670 1.2508 1.80 -0.5263 31 ?
  80.0576405 11.0652 80.058370 0.8494 1.87 -0.1432 41 ?
  80.9451182 11.4236 80.945845 0.9142 3.33 -0.5858 40 ?
  84.0807545 6.6838 84.081470 1.1537 1.51 0.2246 33 ?
  86.0712733 11.6572 86.071980 1.0573 6.11 0.9158 33 f{C3H8N3}/-0.00ppm,p-C1O1
  86.0964434 14.4074 86.097150 1.1731 2.32 0.2402 41 ?
  90.9476596 5.1091 90.948340 1.4954 1.09 -0.0925 32 ?
  91.0574503 6.9867 91.058130 1.3508 1.74 0.0118 33 ?
  96.0807901 105.8162 96.081435 0.4371 7.00 -0.0185 42 ?
  97.0648328 39.0727 97.065470 0.8036 3.86 -0.0379 41 ?
  112.0505730 24.9519 112.051080 1.4725 25.88 -0.7584 34 f{C4H6N3O1}/0.31ppm,p-H2
  112.9998003 26.0476 113.000300 0.9115 11.57 0.1739 42 ?
  113.0234005 11.5627 113.023900 1.1856 2.28 -0.0067 40 ?
  113.0347056 6.0197 113.035205 1.4155 1.41 -0.3977 36 ?
  113.0598008 24.9132 113.060300 1.1764 3.41 0.2232 38 ?
  114.0662588 64.8374 114.066750 1.1397 38.49 1.0000 38 f{C4H8N3O1}/0.62ppm,p
  114.0913790 999.0000 114.091870 0.3068 0.00 -0.1382 42 ?
  114.9708062 9.4433 114.971290 1.1394 2.77 -0.7022 39 ?
  115.0947273 69.9492 115.095210 0.5821 5.03 -0.0100 42 ?
  116.9662032 8.0875 116.966670 1.2995 2.37 -0.3922 39 ?
  130.9819267 9.8364 130.982250 1.1528 2.90 -0.7185 36 ?
PK$NUM_PEAK: 39
PK$PEAK: m/z int. rel.int.
  53.038812 5.26 5
  55.018117 35.70 35
  55.054502 26.77 26
  56.049738 30.06 30
  57.033694 8.71 8
  67.054408 26.32 26
  68.049648 25.81 25
  69.033617 28.66 28
  69.070017 129.38 129
  70.065247 127.23 127
  71.049237 12.64 12
  71.085627 10.72 10
  72.044509 5.25 5
  72.080872 15.37 15
  72.937238 41.75 41
  73.046878 9.14 9
  78.949813 12.32 12
  79.054298 169.32 169
  79.948940 6.40 6
  80.057641 11.07 11
  80.945118 11.42 11
  84.080755 6.68 6
  86.071273 11.66 11
  86.096443 14.41 14
  90.947660 5.11 5
  91.057450 6.99 6
  96.080790 105.82 105
  97.064833 39.07 39
  112.050573 24.95 24
  112.999800 26.05 26
  113.023401 11.56 11
  113.034706 6.02 6
  113.059801 24.91 24
  114.066259 64.84 64
  114.091379 999.00 999
  114.970806 9.44 9
  115.094727 69.95 69
  116.966203 8.09 8
  130.981927 9.84 9
//
